Walleye Trading
RARE icon

Walleye Trading’s Ultragenyx Pharmaceutical RARE Stock Holding History

Walleye Trading’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-7,039
Closed -$147K – 4375
2026
Q1 		$147K Sell
7,039
-6,128
-47% -$138K ﹤0.01% 3275
2025
Q4 		$303K Buy
13,167
+4,911
+59% +$161K ﹤0.01% 3151
2025
Q3 		$248K Buy
8,256
+7,616
+1,190% +$228K ﹤0.01% 3216
2025
Q2 		$23.3K Buy
+640
New +$23.1K ﹤0.01% 3947
2024
Q1 		– Sell
-9,113
Closed -$436K – 5230
2023
Q4 		$436K Sell
9,113
-5,535
-38% -$215K ﹤0.01% 3194
2023
Q3 		$522K Buy
14,648
+14,348
+4,783% +$568K ﹤0.01% 2928
2023
Q2 		$13.8K Buy
+300
New +$13.9K ﹤0.01% 4196
2022
Q2 		– Sell
-21,105
Closed -$1.3M – 5575
2022
Q1 		$1.53M Buy
21,105
+16,982
+412% +$1.18M ﹤0.01% 1891
2021
Q4 		$347K Buy
+4,123
New +$335K ﹤0.01% 3339
2021
Q2 		– Sell
-1,033
Closed -$118K – 5473
2021
Q1 		$118K Sell
1,033
-13,816
-93% -$1.88M ﹤0.01% 4008
2020
Q4 		$2.06M Buy
+14,849
New +$1.76M 0.01% 1373
2016
Q1 		– Sell
-216
Closed -$24K – 5747
2015
Q4 		$24K Buy
216
+116
+116% +$11.6K ﹤0.01% 4317
2015
Q3 		$10K Buy
+100
New +$11.4K ﹤0.01% 4389

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Walleye Trading's RARE Position: Q2 2026 in Review

Walleye Trading sold out of Ultragenyx Pharmaceutical (RARE) in Q2 2026, closing a stake of 7,039 shares — an estimated $147K sold.

Walleye Trading first reported a position in RARE in Q3 2015 and held it in 13 quarters. The position peaked at $2.06M in Q4 2020. 99 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Walleye Trading reported no remaining Ultragenyx Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 7,039 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $147K.
  • Walleye Trading first reported a position in Ultragenyx Pharmaceutical in Q3 2015 and held it in 13 quarters.
  • Walleye Trading's Ultragenyx Pharmaceutical position peaked at $2.06M in Q4 2020.
  • 99 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.